Home  >  News
you can get e-magazine links on WhatsApp. Click here
  InDex Pharma receives positive feedback from Japanese PMDA for clinical development of cobitolimod to treat left-sided ulcerative colitis.,   August 17, 2022
  US FDA accepts Roche’s sBLA for Polivy combination for people with previously untreated DLBCL,   August 17, 2022
  US FDA accepts AstraZeneca & Merck’s sNDA for Lynparza in combo with abiraterone and prednisone or prednisolone to treat patients with mCRPC,   August 17, 2022
  Boston Scientific acquires Obsidio,   August 16, 2022
  US FDA grants orphan drug designation to Privo Technologies’ cisplatin to treat CIS of anterior 2/3 of oral cavity,   August 16, 2022
  US FDA approves AstraZeneca & Daiichi Sankyo’s Enhertu as first HER2-directed therapy for patients with previously treated HER2-mutant metastatic NSCLC,   August 13, 2022
  Roche’s Xofluza receives US FDA approval to treat influenza in children aged five years and older,   August 13, 2022
  GSK issues statement regarding US Zantac litigation,   August 13, 2022
  Synlogic announces new drug candidate to treat gout developed in partnership with Ginkgo Bioworks,   August 12, 2022
  Taiwan FDA accepts Everest Medicines’ NDA for Xerava to treat complicated intra-abdominal infections,   August 12, 2022
  US FDA accepts and grants priority review status to Menarini Group’s elacestrant for patients with ER+/HER2- advanced or metastatic breast cancer,   August 12, 2022
  AstraZeneca completes acquisition of TeneoTwo,   August 12, 2022
  Cure Rare Disease gets US FDA approval to administer first-in-human CRISPR therapeutic,   August 11, 2022
  Israel Health Ministry approves BridgeBio, Sentynl & Medison Pharma’s Nulibry to treat MoCD Type A,   August 11, 2022
  BioIVT acquires Scotland-based drug-metabolizing enzymes manufacturer, Cypex,   August 10, 2022
  Sartorius to acquire Albumedix, for £415 million,   August 10, 2022
  US FDA approves Bayer’s sNDA for oral ARi darolutamide in combo with docetaxel to treat mHSPC,   August 09, 2022
  Pfizer to buy biopharma company, Global Blood Therapeutics for $5.4 billion,   August 09, 2022
  US FDA approves Enhertu to treat patients with unresectable or metastatic HER2-low breast cancer,   August 08, 2022
  US FDA approves Myovant & Pfizer’s Myfembree, a once-daily therapy for management of moderate to severe pain associated with endometriosis,   August 08, 2022

Copyright © 2016 Saffron Media Pvt. Ltd |